Dial-Bicarb Trial: Effects of a Lower vs. Higher Concentration of Dialysate Bicarbonate for People Receiving Maintenance Hemodialysis

Study Lead

Alaa Badawi

London Health Sciences Centre

Overview

Dialysis balances the level of acid in people’s blood by adding bicarbonate (i.e., baking soda) to dialysis fluids. Some dialysis units in Canada add bicarbonate at a level of 32 mmol/L, while others use 38 mmol/L. The Dial-Bicarb Trial aims to assess which concentration is better for people’s health.

The trial team includes patient partners, clinicians, and researchers from across Canada. Currently, there are ~2,000 patients randomized in this trial across four Ontario programs (London, Hamilton, Ottawa, and Kingston).

We are currently seeking an Indigenous patient partner with lived hemodialysis experience to support planning for future communication with dialysis sites and to help review patient-facing materials.

  • Compensation for participants: $40/hour

  • Time commitment: Participation will be on an as-needed basis. During the initial months, we estimate 4–6 hours per month to support onboarding and initial review of patient materials. Following onboarding, involvement will be task-specific, with estimated hours provided in advance.

Eligibility

Indigenous patients with lived hemodialysis experience who are located in Ontario

Type of Participation

Patient Partnership

Treatment

Hemodialysis

Location

Ontario

Related studies

  • Kidney Transplant Stakeholders’ Perspectives on the Future of Xenotransplantation in Canada

    Overview:

    Study type: Focus Group, Interview

    January 7, 2026

  • A qualitative study exploring patient and caregiver perspectives and experiences on disaster management in kidney care

    Overview:

    Study type: Interview

    January 7, 2026

  • Equitable Pandemic Communication Strategies to Support Sexual and Gender Minority Transplant Patients

    Overview:

    Study type: Interview

    December 4, 2025